DNA ploidy as a prognostic factor in patients with ovarian carcinoma.
The aim of this work was to establish the dependence between survival and time to progression and the factor which is considered as risk factor i.e. type of DNA ploidy. The DNA ploidy was evaluated in 33 cases of ovary carcinoma selected from 314 cases. The statistically significant difference between the 5 years survivals in patients with DNA aneuploidy and patients with DNA diploidy was observed (13.6% vs 60.9%). What was also found out, was the statistically significant difference between the 5 years survivals without the progression of disease in patients with DNA aneuploidy and patients with DNA diploidy (13.6% vs 55.9%).
Pietrzak
K
K
Department of Gynaecological Oncology, M. Skłodowska-Curie Memorial Cancer Center, Warszawa.
Olszewski
W
W
D000818:Animals; D004273:DNA, Neoplasm / Q000235:genetics*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000235:genetics*; D011003:Ploidies; D011379:Prognosis; D051381:Rats; D012307:Risk Factors
D004273:DNA, Neoplasm